低酸素に誘発された超分子フリーラジカルは,精密な腫瘍治療のための細胞内ポリメリゼーションを誘導する

Mian Tang¹, Zhiqing Yang¹, Xingchen Tang²

¹State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, and MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR 999078, China.

Journal of the American Chemical Society

|January 13, 2025

まとめ

この研究は,がんに対する新しいインサイトポリメリゼーション治療法を紹介しています. 腫瘍細胞内でフリーラジカルを生成し腫瘍細胞を破壊し副作用の少ない標的型抗腫瘍治療を提供します

科学分野:

生物医学工学
材料科学
腫瘍学

背景:

抗腫瘍療法の制御放出システムは,しばしば標的外副作用を引き起こす.
バイオコンパティブルな材料を用いたインシット治療合成はより安全な代替手段です

研究の目的:

細胞内ポリメリゼーションと標的がん治療のための低酸素誘発超分子自由基システムを開発する.
4T1細胞の破壊を in situ ポリメリゼーションで調査する.

主な方法:

キュキュルビット[7]ウリル (CB[7]) とペリレンダイミド誘導体 (PDI) (PDI+2CB[7]) の2:1超分子宿主-ゲスト複合体を使用した.
腫瘍の低酸素環境を利用して自由アニオンを生成した
PDI+2CB[7]複合体を用いて4T1細胞内で,2-ヒドロキシエチルメタクリレート (HEMA) のフリーラジカル聚合を開始した.

主要な成果:

PDI+2CB[7]複合体は,4T1細胞内で安定したフリーラジカルアニオンを生成した.
4T1細胞の細胞骨格と臓器をインシットポリメリゼーションで破壊した.
重要な腫瘍代謝障害と,全身の毒性のない強力な抗腫瘍反応を達成した.

結論:

安定した内生刺激誘発の超分子自由基は細胞内ポリメリゼーションを誘発する.
このアプローチは,従来の化学療法薬を必要とせずに,選択的で効果的な抗腫瘍療法を提供します.
より安全で正確な癌治療のための有望な戦略を示した.

さらに関連する動画

13:21

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids

Published on: April 6, 2022

3.3K

14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.2K

関連する概念動画

01:24

Regulation of Angiogenesis and Blood Supply

2.5K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

2.5K

02:53

Adaptive Mechanisms in Cancer Cells

5.7K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.7K

02:49

Cancer Therapies

7.5K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.5K

02:57

Targeted Cancer Therapies

7.4K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.4K

01:46

Electron Transport Chain: Complex I and II

10.9K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

10.9K

01:10

Radical Chain-Growth Polymerization: Overview

2.4K

Chain-growth or addition polymerization is successive addition reactions of monomers with a polymer chain. In radical chain-growth polymerization, the reaction proceeds via a free-radical intermediate. The free radical is formed from radical initiators, which spontaneously generate free radicals by homolytic fission. Organic peroxides (such as dibenzoyl peroxide, as shown in Figure 1) or azo compounds are popular radical initiators. A low concentration ratio of radical initiator to monomer is...